Monitoring methotrexate toxicity: Are we being over-vigilant?

Mednet Member

Rheumatology · Harvard Medical School

Lab monitoring for patients taking MTX should be based on a few key principles. It should be done at least on a quarterly basis, ie every 3 months, if the patient is prescribed a stable dose and does not belong to one of the higher risk categories for the development of toxicities. These risk factor...